Chemicals · Founded 2005 · www.sanginitachemicals.co.in · NSE · ISIN INE753W01010
No Notes Added Yet
Business
Sanginita Chemicals Ltd. is an Indian chemical manufacturing company primarily engaged in the production of various industrial chemicals. The company focuses on the specialty chemicals segment, supplying products to diverse industries such as textiles, paper, dyes & intermediates, pharmaceuticals, and water treatment. Their core business model involves manufacturing these chemicals, leveraging their production facilities, and selling them to B2B customers. They make money through the sale of their manufactured chemical products, catering to domestic demand and potentially export markets.
Revenue Mix
Sanginita Chemicals primarily operates within the 'Chemicals' segment. While specific revenue contribution percentages for different product lines are not typically disclosed in detail for such companies, their product portfolio generally includes:
Sulphuric Acid and its derivatives
Oleum
Chlorosulphonic Acid
Sulphur Trioxide
Other specialty chemicals catering to various industrial applications.
The company's revenue mix is largely driven by the demand for these core products from its industrial client base.
Industry
The Indian chemicals industry is vast and diverse, comprising both commodity and specialty chemicals. It is characterized by fragmentation, with numerous small to medium-sized players alongside a few large integrated ones. Sanginita Chemicals operates within the specialty chemicals segment, which typically involves higher value-added products and can offer better margins than bulk chemicals. The company likely positions itself as a reliable supplier for specific chemical intermediates, often competing on product quality, consistency, and competitive pricing, especially for regional customers. Its positioning is generally as a mid-tier player within its specific product niches.
MOAT
Sanginita Chemicals' competitive advantages are likely derived from:
Process Expertise: Developed know-how and experience in manufacturing complex chemical compounds, ensuring consistent quality and efficient production.
Customer Relationships: Long-standing relationships with industrial clients built on trust and reliability of supply.
Regulatory Compliance: Adherence to environmental and safety regulations, which is crucial in the chemical industry and can be a barrier to entry for new players.
Geographic Proximity: Proximity to key raw material sources or end-user industries can offer logistics and cost advantages in specific regions of India.
Strong brand recognition or significant economies of scale across the entire chemical industry might be less pronounced compared to global giants, but they might hold a strong position in their specific product categories.
Growth Drivers
Key factors that can drive growth for Sanginita Chemicals over the next 3-5 years include:
Growth in End-User Industries: Increased demand from client sectors such as textiles, pharmaceuticals, agrochemicals, and paper, driven by India's economic growth and manufacturing expansion.
Capacity Expansion: Investment in increasing production capacity to meet growing demand and capture a larger market share.
Product Diversification: Introduction of new specialty chemicals or value-added derivatives to cater to emerging industrial needs.
Import Substitution: Government focus on 'Make in India' and import substitution can create opportunities for domestic manufacturers.
Export Opportunities: Tapping into international markets, particularly for specialty chemicals where Indian manufacturers are becoming increasingly competitive.
Risks
Raw Material Price Volatility: Fluctuations in the prices of key raw materials (e.g., sulfur, energy inputs) can impact profitability.
Environmental Regulations: Stringent and evolving environmental regulations, including waste disposal and emissions, can lead to increased compliance costs or operational restrictions.
Competition: Intense competition from both domestic and international players, especially in a fragmented market.
Demand Cyclicality: Demand for industrial chemicals can be cyclical, tied to the broader economic health and specific industry performance.
Technological Obsolescence: Rapid advancements in chemical processes or new product formulations could render existing technologies less competitive.
Foreign Exchange Fluctuations: If the company engages in significant imports of raw materials or exports of finished goods, currency volatility can affect margins.
Management & Ownership
Sanginita Chemicals Ltd. is typically promoted and managed by its founding family or a core promoter group, which is common among mid-sized Indian companies. The promoters hold a significant stake in the company, aligning their interests with long-term growth. The management team likely possesses experience within the chemical manufacturing sector, overseeing day-to-day operations and strategic direction. Information on specific management quality usually requires detailed annual report analysis or public perception assessment, but generally, promoter-driven companies emphasize operational control and long-term vision.
Outlook
Sanginita Chemicals operates in a vital and growing sector within India's industrial landscape. The increasing demand from various end-user industries, coupled with government initiatives supporting domestic manufacturing, presents a favorable growth environment. The company's focus on specialty chemicals can offer better margins and resilience compared to commodity chemicals. However, the business faces inherent risks from raw material price volatility, stringent environmental regulations, and intense competition. Its ability to manage these risks, innovate its product portfolio, and strategically expand capacity will be crucial for sustained profitability and market position. The outlook is cautiously optimistic, dependent on the company's operational efficiency, strategic capital allocation, and ability to adapt to industry-specific challenges and opportunities.
| #(Fig in Cr.) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 33 | 29 | 53 | 57 | 61 | 62 | 50 | 44 | 43 | 43 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 33 | 29 | 53 | 57 | 61 | 62 | 50 | 44 | 43 | 43 |
| Total Expenditure | 32 | 28 | 53 | 56 | 60 | 60 | 49 | 44 | 45 | 48 |
| Operating Profit | 2 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | -2 | -5 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | -1 | 0 | 0 | 0 | -0 | -1 | -3 | -6 |
| Provision for Tax | 0 | 0 | -0 | 0 | 0 | 0 | -0 | -0 | -0 | -0 |
| Profit After Tax | 1 | 0 | -1 | 0 | 0 | 0 | -0 | -1 | -3 | -6 |
| Adjustments | -0 | -0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 |
| Profit After Adjustments | 1 | 0 | -1 | 0 | 0 | 0 | -0 | -1 | -3 | -6 |
| Adjusted Earnings Per Share | 0.3 | 0.3 | -0.3 | 0.1 | 0.1 | 0.1 | -0 | -0.3 | -1.1 | -2.4 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 129 | 151 | 155 | 195 | 188 | 160 | 165 | 198 | 149 | 152 | 230 | 180 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Total Income | 129 | 152 | 155 | 195 | 188 | 160 | 165 | 198 | 149 | 152 | 230 | 180 |
| Total Expenditure | 124 | 147 | 150 | 187 | 178 | 152 | 161 | 195 | 146 | 148 | 225 | 186 |
| Operating Profit | 5 | 5 | 5 | 8 | 9 | 8 | 4 | 3 | 4 | 4 | 5 | -6 |
| Interest | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 2 | 2 | 3 | 2 | 1 |
| Depreciation | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 2 | 2 | 5 | 5 | 5 | 1 | 0 | 1 | 1 | 1 | -10 |
| Provision for Tax | 0 | 1 | 1 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | 1 | 1 | 1 | 3 | 4 | 3 | 1 | 0 | 0 | 1 | 1 | -10 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 1 | 1 | 1 | 3 | 4 | 3 | 1 | 0 | 0 | 1 | 1 | -10 |
| Adjusted Earnings Per Share | 0 | 0 | 0.6 | 2 | 2.3 | 1.9 | 0.4 | 0.2 | 0.2 | 0.4 | 0.2 | -3.8 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 51% | 5% | 8% | 6% |
| Operating Profit CAGR | 25% | 19% | -9% | 0% |
| PAT CAGR | 0% | 0% | -20% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 496% | 41% | 17% | NA% |
| ROE Average | 1% | 1% | 1% | 5% |
| ROCE Average | 4% | 5% | 4% | 8% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 15 | 17 | 28 | 31 | 35 | 39 | 39 | 40 | 40 | 41 | 56 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 4 | 2 | 3 | 1 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 34 | 26 | 31 | 29 | 36 | 39 | 31 | 36 | 37 | 42 | 45 |
| Total Liabilities | 50 | 44 | 60 | 61 | 72 | 78 | 70 | 79 | 79 | 86 | 102 |
| Fixed Assets | 4 | 4 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 7 | 15 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 5 | 1 | 1 |
| Total Current Assets | 46 | 40 | 56 | 57 | 67 | 74 | 66 | 75 | 70 | 78 | 87 |
| Total Assets | 50 | 44 | 60 | 61 | 72 | 78 | 70 | 79 | 79 | 86 | 102 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Flow from Operating Activities | 2 | 0 | -7 | 3 | 1 | -2 | 9 | -3 | 14 | -2 | 3 |
| Cash Flow from Investing Activities | 0 | -0 | -0 | -1 | -1 | -1 | -0 | -0 | -1 | -4 | -10 |
| Cash Flow from Financing Activities | -2 | -0 | 8 | -2 | 0 | 2 | -8 | 4 | -13 | 6 | 7 |
| Net Cash Inflow / Outflow | -0 | 0 | 0 | -0 | 0 | -0 | -0 | 0 | 0 | -0 | -0 |
| Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0 | 0 | 0.65 | 2 | 2.28 | 1.95 | 0.44 | 0.2 | 0.24 | 0.45 | 0.24 |
| CEPS(Rs) | 1.28 | 1.26 | 0.91 | 2.27 | 2.66 | 2.35 | 0.79 | 0.54 | 0.56 | 0.88 | 0.89 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 0 | 0 | 16.13 | 18.13 | 20.41 | 22.36 | 22.8 | 23 | 23.24 | 23.62 | 21.68 |
| Core EBITDA Margin(%) | 3.01 | 2.71 | 2.86 | 3.45 | 4.88 | 5.17 | 2.33 | 1.38 | 2.05 | 2.61 | 2.04 |
| EBIT Margin(%) | 2.81 | 2.55 | 2.68 | 3.33 | 4.61 | 4.88 | 2.18 | 1.28 | 2.05 | 2.42 | 1.42 |
| Pre Tax Margin(%) | 1.02 | 0.95 | 0.99 | 2.26 | 2.91 | 2.82 | 0.62 | 0.23 | 0.37 | 0.69 | 0.36 |
| PAT Margin (%) | 0.7 | 0.65 | 0.65 | 1.51 | 2.1 | 2.11 | 0.46 | 0.18 | 0.28 | 0.51 | 0.27 |
| Cash Profit Margin (%) | 1.1 | 0.94 | 0.91 | 1.71 | 2.45 | 2.54 | 0.83 | 0.47 | 0.65 | 1 | 1 |
| ROA(%) | 2.13 | 2.35 | 2.15 | 5.71 | 5.95 | 4.49 | 1.03 | 0.47 | 0.52 | 0.93 | 0.66 |
| ROE(%) | 6.78 | 6.91 | 5.02 | 11.67 | 11.85 | 9.12 | 1.96 | 0.88 | 1.04 | 1.9 | 1.28 |
| ROCE(%) | 10.76 | 10.79 | 9.66 | 13.71 | 14.16 | 11.28 | 5.05 | 3.55 | 4.27 | 5.15 | 4.18 |
| Receivable days | 65.42 | 61.55 | 71.31 | 60.65 | 65.52 | 81.01 | 75.77 | 50.03 | 62.14 | 62.51 | 50.09 |
| Inventory Days | 36.03 | 27.04 | 23.66 | 20.07 | 32.32 | 44.9 | 46.84 | 42.17 | 62.41 | 68.5 | 47.42 |
| Payable days | 22.72 | 15.34 | 8.48 | 7.18 | 5.6 | 8.51 | 4.46 | 4.74 | 17.91 | 26.04 | 20.12 |
| PER(x) | 0 | 0 | 33.34 | 23.53 | 25.36 | 34.23 | 39.44 | 93.84 | 71.14 | 39.58 | 37.65 |
| Price/Book(x) | 0 | 0 | 1.34 | 2.6 | 2.84 | 2.98 | 0.76 | 0.82 | 0.74 | 0.75 | 0.41 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.24 | 0.22 | 0.43 | 0.6 | 0.75 | 1.02 | 0.38 | 0.36 | 0.41 | 0.44 | 0.22 |
| EV/Core EBITDA(x) | 6.72 | 6.97 | 13.19 | 14.35 | 15.04 | 19.12 | 14.83 | 22.7 | 17 | 15.09 | 10.05 |
| Net Sales Growth(%) | 8.08 | 17.74 | 2.15 | 25.74 | -3.58 | -14.83 | 3.05 | 20.29 | -24.99 | 1.98 | 51.6 |
| EBIT Growth(%) | 180.63 | 6.97 | 6.89 | 65.4 | 13.52 | -9.92 | -54 | -29.38 | 20.56 | 20.1 | -10.92 |
| PAT Growth(%) | 19.14 | 10.01 | 1.17 | 208.92 | 14.21 | -14.63 | -77.35 | -54.37 | 19.57 | 85 | -19.65 |
| EPS Growth(%) | 0 | 0 | -25.58 | 208.92 | 14.21 | -14.63 | -77.35 | -54.37 | 19.6 | 84.98 | -46.43 |
| Debt/Equity(x) | 1.49 | 1.51 | 0.92 | 0.84 | 0.83 | 0.91 | 0.74 | 0.87 | 0.71 | 0.81 | 0.47 |
| Current Ratio(x) | 1.36 | 1.53 | 1.8 | 1.97 | 1.86 | 1.87 | 2.16 | 2.09 | 1.89 | 1.85 | 1.93 |
| Quick Ratio(x) | 0.96 | 1.09 | 1.45 | 1.47 | 1.34 | 1.35 | 1.44 | 1.42 | 1.16 | 1.14 | 1.27 |
| Interest Cover(x) | 1.57 | 1.6 | 1.59 | 3.12 | 2.71 | 2.37 | 1.4 | 1.23 | 1.22 | 1.4 | 1.34 |
| Total Debt/Mcap(x) | 0 | 0 | 0.62 | 0.29 | 0.27 | 0.27 | 0.87 | 0.96 | 0.87 | 0.98 | 1.13 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 60.23 | 43.49 | 37.24 | 37.24 | 37.24 | 37.24 | 30 | 26.67 | 25.4 | 68 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.19 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 39.77 | 56.51 | 62.76 | 62.76 | 62.76 | 62.76 | 70 | 73.33 | 74.41 | 32 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.04 | 1.13 | 0.96 | 0.96 | 0.96 | 0.96 | 0.78 | 0.69 | 0.66 | 4.1 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.69 | 1.46 | 1.63 | 1.63 | 1.63 | 1.63 | 1.81 | 1.9 | 1.93 | 1.93 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.73 | 2.59 | 2.59 | 2.59 | 2.59 | 2.59 | 2.59 | 2.59 | 2.59 | 6.03 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +51% | +5% | +8% | +6% |
| Operating Profit CAGR | +25% | +19% | -9% | 0% |
| PAT CAGR | 0% | — | -20% | 0% |
| Share Price CAGR | +496% | +41% | +17% | — |
| ROE Average | +1% | +1% | +1% | +5% |
| ROCE Average | +4% | +5% | +4% | +8% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 60.23 | 43.49 | 37.24 | 37.24 | 37.24 | 37.24 | 30 | 26.67 | 25.4 | 68 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.19 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 39.77 | 56.51 | 62.76 | 62.76 | 62.76 | 62.76 | 70 | 73.33 | 74.41 | 32 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.04 | 1.13 | 0.96 | 0.96 | 0.96 | 0.96 | 0.78 | 0.69 | 0.66 | 4.1 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.69 | 1.46 | 1.63 | 1.63 | 1.63 | 1.63 | 1.81 | 1.9 | 1.93 | 1.93 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.73 | 2.59 | 2.59 | 2.59 | 2.59 | 2.59 | 2.59 | 2.59 | 2.59 | 6.03 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.